Extended-release divalproex in bipolar and other psychiatric disorders: A comprehensive review
Steven C Stoner1, Megan M Dahmen21Northwest Missouri Psychiatric Rehabilitation Center, Department of Pharmacy, St. Joseph, Missouri, USA; 2University of Missouri-Kansas City School of Pharmacy, Division of Pharmacy Practice, Kansas City, Missouri, USAAbstract: Bipolar disorder can be a devastating...
Enregistré dans:
Auteurs principaux: | Steven C Stoner, Megan M Dahmen |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2007
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/89a832f8d35144ababa9170a0a95e6f3 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Role of extended release quetiapine in the management of bipolar disorders
par: Rayan K Al Jurdi, et autres
Publié: (2010) -
The role of paliperidone extended release for the treatment of bipolar disorder
par: Marino J, et autres
Publié: (2012) -
Update on extended release quetiapine fumarate in schizophrenia and bipolar disorders
par: El-Khalili N
Publié: (2012) -
Management of obsessive-compulsive disorder with fluvoxamine extended release
par: Lídia Ordacgi, et autres
Publié: (2009) -
Role of paliperidone extended-release in treatment of schizoaffective disorder
par: Carla M Canuso, et autres
Publié: (2010)